TY - JOUR AU - Aletaha, D. AU - Neogi, T. AU - Silman, A. J. AU - Funovits, J. AU - Felson, D. T. AU - Bingham, C. O. PY - 2010 DA - 2010// TI - 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative JO - Arthritis Rheum. VL - 62 UR - https://doi.org/10.1002/art.27584 DO - 10.1002/art.27584 ID - Aletaha2010 ER - TY - JOUR AU - Coulthard, L. R. AU - Geiler, J. AU - Mathews, R. J. AU - Church, L. D. AU - Dickie, L. J. AU - Cooper, D. L. PY - 2012 DA - 2012// TI - Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients JO - Clin Exp Immunol. VL - 170 UR - https://doi.org/10.1111/j.1365-2249.2012.04626.x DO - 10.1111/j.1365-2249.2012.04626.x ID - Coulthard2012 ER - TY - JOUR AU - Raza, K. AU - Falciani, F. AU - Curnow, S. J. AU - Ross, E. J. AU - Lee, C. Y. AU - Akbar, A. N. PY - 2005 DA - 2005// TI - Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin JO - Arthritis Res Ther. VL - 7 UR - https://doi.org/10.1186/ar1733 DO - 10.1186/ar1733 ID - Raza2005 ER - TY - JOUR AU - Smolen, J. S. AU - Heijde, D. M. AU - St Clair, E. W. AU - Emery, P. AU - Bathon, J. M. AU - Keystone, E. PY - 2006 DA - 2006// TI - Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial JO - Arthritis Rheum. VL - 54 UR - https://doi.org/10.1002/art.21678 DO - 10.1002/art.21678 ID - Smolen2006 ER - TY - JOUR AU - Emery, P. AU - Genovese, M. C. AU - Vollenhoven, R. AU - Sharp, J. T. AU - Patra, K. AU - Sasso, E. H. PY - 2010 DA - 2010// TI - Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol. 2009;36:1429–41. A published erratum appears in JO - J Rheumatol. VL - 37 UR - https://doi.org/10.3899/jrheum.081018C1 DO - 10.3899/jrheum.081018C1 ID - Emery2010 ER - TY - JOUR AU - Smolen, J. S. AU - Han, C. AU - Bala, M. AU - Maini, R. N. AU - Kalden, J. R. AU - Heijde, D. PY - 2005 DA - 2005// TI - Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy study JO - Arthritis Rheum. VL - 52 UR - https://doi.org/10.1002/art.20982 DO - 10.1002/art.20982 ID - Smolen2005 ER - TY - JOUR AU - Landewé, R. AU - Heijde, D. AU - Klareskog, L. AU - Vollenhoven, R. AU - Fatenejad, S. PY - 2006 DA - 2006// TI - Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes JO - Arthritis Rheum. VL - 54 UR - https://doi.org/10.1002/art.22143 DO - 10.1002/art.22143 ID - Landewé2006 ER - TY - JOUR AU - Aletaha, D. AU - Alasti, F. AU - Smolen, J. S. PY - 2013 DA - 2013// TI - Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients JO - Ann Rheum Dis. VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201970 DO - 10.1136/annrheumdis-2012-201970 ID - Aletaha2013 ER - TY - JOUR AU - Kilani, R. T. AU - Maksymowych, W. P. AU - Aitken, A. AU - Boire, G. AU - St-Pierre, Y. AU - Li, Y. PY - 2007 DA - 2007// TI - Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation JO - J Rheumatol. VL - 34 ID - Kilani2007 ER - TY - JOUR AU - Maksymowych, W. P. AU - Naides, S. J. AU - Bykerk, V. AU - Siminovitch, K. A. AU - Schaardenburg, D. AU - Boers, M. PY - 2014 DA - 2014// TI - Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis JO - J Rheumatol. VL - 41 UR - https://doi.org/10.3899/jrheum.131446 DO - 10.3899/jrheum.131446 ID - Maksymowych2014 ER - TY - STD TI - Marotta A, Cherkas Y, Dasgupta B, Lamberth S, Hayden K, Brodmerkel C, et al. Serum 14–3-3η is an RA specific mechanistic marker [abstract B030]. Inflamm Res. 2015;64 Suppl 2:S114. ID - ref11 ER - TY - JOUR AU - Naides, S. J. AU - Zhukov, O. S. AU - Rivera, J. G. AU - Abolhosn, R. W. AU - Rowland, C. M. AU - Popov, J. M. PY - 2015 DA - 2015// TI - Serum 14-3-3η protein differentiates osteoarthritis from inflammatory arthritis [poster 0168] JO - Ann Rheum Dis VL - 74 Suppl 2 ID - Naides2015 ER - TY - STD TI - Hughes N, Boss S, Longe R, Sohal R, Jimenez C, Gui Y, et al. Independent validation of the 14-3-3η assay: a diagnostic RA marker [abstract 111]. Presented at the 2015 Canadian Rheumatology Association (CRA) Annual Meeting, Quebec, QC, Canada, 5 February 2015. ID - ref13 ER - TY - JOUR AU - Naides, S. J. AU - Zhukov, O. S. AU - Abolhosn, R. W. AU - Popov, J. M. PY - 2013 DA - 2013// TI - Chaperonin protein 14-3-3n (η) in rheumatoid arthritis and arthritogenic viral infections [abstract 1390] JO - Arthritis Rheum. VL - 65 ID - Naides2013 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum. VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Gestel, A. M. AU - Prevoo, M. L. PY - 1996 DA - 1996// TI - van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780390105 DO - 10.1002/art.1780390105 ID - Gestel1996 ER - TY - JOUR AU - Maksymowych, W. P. AU - Heijde, D. AU - Allaart, C. F. AU - Landewé, R. AU - Boire, G. AU - Tak, P. P. PY - 2014 DA - 2014// TI - 14–3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage JO - Arthritis Res Ther. VL - 16 UR - https://doi.org/10.1186/ar4547 DO - 10.1186/ar4547 ID - Maksymowych2014 ER - TY - JOUR AU - Wu, Q. AU - Liu, C. Z. AU - Tao, L. Y. AU - Yu, L. AU - Liu, W. AU - Chen, S. S. PY - 2012 DA - 2012// TI - The clinicopathological and prognostic impact of 14–3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry JO - Asian Pac J Cancer Prev. VL - 13 UR - https://doi.org/10.7314/APJCP.2012.13.4.1253 DO - 10.7314/APJCP.2012.13.4.1253 ID - Wu2012 ER - TY - STD TI - Nakamura Y, Oshima K, Naoi Y, Nakayama T, Kim SJ, Shimazu K, et al. 14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers. Breast Cancer Res Treat. 2012;134:229–36.  ID - ref19 ER - TY - JOUR AU - Zhou, W. H. AU - Tang, F. AU - Xu, J. AU - Wu, X. AU - Feng, Z. Y. AU - Li, H. G. PY - 2011 DA - 2011// TI - Aberrant upregulation of 14–3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer JO - BMC Cancer. VL - 11 UR - https://doi.org/10.1186/1471-2407-11-397 DO - 10.1186/1471-2407-11-397 ID - Zhou2011 ER - TY - JOUR AU - Ko, B. S. AU - Chang, T. C. AU - Hsu, C. AU - Chen, Y. C. AU - Shen, T. L. AU - Chen, S. C. PY - 2011 DA - 2011// TI - Overexpression of 14–3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma JO - Histopathology. VL - 58 UR - https://doi.org/10.1111/j.1365-2559.2011.03789.x DO - 10.1111/j.1365-2559.2011.03789.x ID - Ko2011 ER - TY - JOUR AU - Boesenberg-Grosse, C. AU - Schulz-Schaeffer, W. J. AU - Bodemer, M. AU - Ciesielczyk, B. AU - Meissner, B. AU - Krasnianski, A. PY - 2006 DA - 2006// TI - Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD? JO - BMC Neurol. VL - 6 UR - https://doi.org/10.1186/1471-2377-6-35 DO - 10.1186/1471-2377-6-35 ID - Boesenberg-Grosse2006 ER - TY - JOUR AU - Jayaratnam, S. AU - Khoo, A. K. AU - Basic, D. PY - 2008 DA - 2008// TI - Rapidly progressive Alzheimer’s disease and elevated 14–3-3 proteins in cerebrospinal fluid JO - Age Ageing. VL - 37 UR - https://doi.org/10.1093/ageing/afn094 DO - 10.1093/ageing/afn094 ID - Jayaratnam2008 ER - TY - JOUR AU - Colucci, M. AU - Roccatagliata, L. AU - Capello, E. AU - Narciso, E. AU - Latronico, N. AU - Tabaton, M. PY - 2004 DA - 2004// TI - The 14–3-3 protein in multiple sclerosis: a marker of disease severity JO - Mult Scler. VL - 10 UR - https://doi.org/10.1191/1352458504ms1089oa DO - 10.1191/1352458504ms1089oa ID - Colucci2004 ER - TY - JOUR AU - Umahara, T. AU - Uchihara, T. AU - Tsuchiya, K. AU - Nakamura, A. AU - Iwamoto, T. PY - 2007 DA - 2007// TI - Intranuclear localization and isoform-dependent translocation of 14–3-3 proteins in human brain with infarction JO - J Neurol Sci. VL - 260 UR - https://doi.org/10.1016/j.jns.2007.04.053 DO - 10.1016/j.jns.2007.04.053 ID - Umahara2007 ER - TY - JOUR AU - Miller, R. F. AU - Green, A. J. AU - Giovannoni, G. AU - Thompson, E. J. PY - 2000 DA - 2000// TI - Detection of 14–3-3 brain protein in cerebrospinal fluid of HIV infected patients JO - Sex Transm Infect. VL - 76 UR - https://doi.org/10.1136/sti.76.5.408 DO - 10.1136/sti.76.5.408 ID - Miller2000 ER - TY - STD TI - O’Mahony A, Berg EL, Maksymowych WP, Gui Y, Marotta A. Profiling of 14–3-3η in human primary cell based BioMAP disease models reveals a unique pro-inflammatory phenotypic signature consistent with RA-inflammation biology [abstract 1975]. Arthritis Rheum. 2014;63 Suppl 10:S868. ID - ref27 ER - TY - STD TI - Abulrob A, Mercier M, Corluka S, MacKenzie R, Raphael S, Michienzi S, et al. 14–3-3η as a novel RA drug target: anti-14-3-3η monoclonal antibody delays the onset and mitigates the severity of arthritis in CIA mice [poster 0073]. Ann Rheum Dis. 2015;74 Suppl 2:218. ID - ref28 ER - TY - JOUR AU - Barra, L. AU - Bykerk, V. AU - Pope, J. E. AU - Haraoui, B. P. AU - Hitchon, C. A. AU - Thorne, J. C. PY - 2013 DA - 2013// TI - Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes JO - J Rheumatol. VL - 40 UR - https://doi.org/10.3899/jrheum.120736 DO - 10.3899/jrheum.120736 ID - Barra2013 ER - TY - STD TI - Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7. A published erratum appears in Ann Rheum Dis. 2011;70:1519. ID - ref30 ER -